Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Ligand Pharmaceuticals amends merger with XOMA Royalty
PUBLIC · LGNDMay 18, 2026•about 2 months ago
Acquiring Company
Ligand Pharmaceuticals Incorporated
Acquired Company
XOMA Royalty Corporation
San DiegoEmeryvilleBiotechnologyHealthcareHealth CarePharmaceuticalBiopharmaBiotechnologyHealth Care
Description
Ligand Pharmaceuticals has amended its merger agreement with XOMA Royalty to include XOMA Royalty Holdings. This change supports a reorganization under which Ligand's Merger Sub will merge with HoldCo. The aim is to streamline the acquisition process of XOMA Royalty. The amendment was signed on May 16, 2026.
Company Information
Company
Ligand Pharmaceuticals Incorporated
Location
San Diego, California, United States
About
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company enabling scientific advancement through supporting the clinical development of high-value medicines. Their business model seeks to generate value for stockholders by creating a diversified portfolio of biotech and pharmaceutical product revenue streams that are supported by an efficient and low corporate cost structure.
San Diego